Zydus Wellness share price
NSE: ZYDUSWELLBSE: 531335Food ProductsSmall Cap
Zydus Wellness Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1996 on BSE, Nov 2009 on NSE
Last close ₹463.60down ₹8.40 (1.78%)BSE ₹463.85
Share price at the NSE close on 28 Oct 2026. Previous close ₹472.00.
28 Oct: open ₹470.00, high ₹477.35, low ₹462.00
52-week range of traded prices to 28 Oct 2026
₹367.55Low, 2 Mar 2026₹611.85High, 20 Jul 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹14,750 Cr434th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 78.37
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹41 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 64.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.53
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.26%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 3.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹41 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 4.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.55
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 58,62743.3% delivered
About Zydus Wellness
Zydus Wellness Limited develops, manufactures, markets and distributes health and wellness products. Its brands include Sugar Free, I'm lite, Glucon-D, Complan, Nutralite, Everyuth, Nycil, Cuticolor and RiteBite Max Protein. It is headquartered in Ahmedabad. It was incorporated in 1994, and its shares are listed on BSE Limited and the National Stock Exchange of India.
The company operates across nutrition and wellness segments, including sugar substitutes, energy drinks, nutritional drinks, low-calorie foods, protein snacks and bars, and personal care products. Through Comfort Click, a United Kingdom business it acquired, it also sells vitamins, minerals and supplements for adults, children and pets under the WeightWorld, Maxmedix and Animigo brands.
Its manufacturing plants hold FSSC 22000, ISO 14001:2015 and ISO 45001:2018 accreditations. In India, they are at Sanand near Ahmedabad, at Aligarh in Uttar Pradesh and at two units in Sikkim. Its products reach approximately 2.8 million retail outlets through a network of more than 1,950 distributors, a figure that excludes Comfort Click. A sales force of over 2,700 field representatives supports them, on the same basis. It operates in over 44 countries, with international markets in the Middle East, Asia, Africa, Oceania, Europe and North America.
The Sugar Free and Everyuth brands were moved to the company from Zydus Lifesciences. In the year to March 2026, the company's wholly owned subsidiary Alidac UK Limited acquired Comfort Click Limited in the United Kingdom, its first overseas acquisition. The company belongs to the Zydus Group.
Written from the annual report for the year to Mar 2026, filed 10 Jul 2026 and the investor presentation.
Sources for 33 statements, each with its page
- It develops, manufactures, markets and distributes health and wellness products. Annual report, page 8
- Brands Sugar Free, I'm lite, Glucon-D, Nutralite. Annual report, page 7
- Brands Everyuth, Nycil, Complan. Annual report, page 7
- Brand RiteBite Max Protein. Annual report, page 7
- Listed on BSE and NSE. Annual report, page 7
- Plants accredited FSSC 22000, ISO 14001:2015 and ISO 45001:2018. Annual report, page 7
- Sales force over 2,700. Annual report, page 10
- Cuticolor brand. Annual report, page 7
- Headquartered in Ahmedabad. Annual report, page 10
- Incorporated in 1994 (CIN year). Annual report, page 5
- Operates across wellness and nutrition segments including sugar substitutes. Annual report, page 7
- Comfort Click enters vitamins, minerals and supplements for adults, kids and pets. Annual report, page 10
- WeightWorld brand. Annual report, page 10
- Maxmedix brand. Annual report, page 10
- Animigo brand. Annual report, page 10
- Plant at Sanand near Ahmedabad. Annual report, page 5
- Plant at Aligarh, Uttar Pradesh. Annual report, page 5
- Sikkim Unit I. Annual report, page 5
- Sikkim Unit II. Annual report, page 5
- Approximately 2.8 million retail outlets. Annual report, page 10
- More than 1,950 distributors. Annual report, page 10
- Figure excludes Comfort Click. Annual report, page 10
- Over 44 countries. Annual report, page 10
- Middle East market. Annual report, page 10
- Asia market. Annual report, page 10
- Africa market. Annual report, page 10
- Oceania market. Annual report, page 10
- Europe market. Annual report, page 10
- North America market. Annual report, page 10
- Sugar Free and Everyuth moved from Zydus Lifesciences. Annual report, page 9
- Alidac UK Limited, wholly owned subsidiary, acquired Comfort Click Limited in the UK in the year to March 2026. Annual report, page 10
- It was its first overseas acquisition. Annual report, page 10
- Belongs to the Zydus Group. Annual report, page 53
Results
Consolidated; ₹ crore.Zydus Wellness quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +66.3%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- −42.5%
Quarter to Jun 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹1,437 Crdown 3.21%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹119 Crdown 26.60%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 8.3%
Revenue by quarter
Peak revenue ₹1,485 Cr, quarter to Mar 2026; lowest ₹462 Cr, quarter to Dec 2024
Net profit by quarter, a loss in red
- Net profit
- Loss
A loss in 2 of the 8 quarters shown
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 493 | 462 | 913 | 861 | 651 | 965 | 1,485 | 1,437 |
| Net profit | 21 | 6 | 172 | 128 | −53 | −40 | 162 | 119 |
| Net margin | 4.2% | 1.4% | 18.8% | 14.9% | −8.1% | −4.1% | 10.9% | 8.3% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹3,961 Crup 46.22%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹197 Crdown 43.15%
- Net margin
- 5.0%
Revenue by year
Peak revenue ₹3,961 Cr, year to Mar 2026; lowest ₹463 Cr, year to Mar 2017
Net profit by year, a loss in red
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 463 | 503 | 843 | 1,767 | 1,867 | 2,009 | 2,255 | 2,328 | 2,709 | 3,961 |
| Net profit | 111 | 134 | 169 | 142 | 119 | 309 | 310 | 267 | 347 | 197 |
| Net margin | 24.1% | 26.6% | 20.1% | 8.0% | 6.4% | 15.4% | 13.8% | 11.5% | 12.8% | 5.0% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Consumer Products, which carries all its revenue.
Valuation
Today, against the company's own history.Zydus Wellness PE ratio and valuation
Price to earnings
At or below today's level on 89% of 2,352 trading days over the last 10 years.
LowestHighest
Its median38.10Industry median29.92
Price to book
At or below today's level on 60% of 1,929 trading days since Nov 2018.
LowestHighest
Its median2.34Industry median1.88
Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.
At or below today's level on 25% of 2,469 trading days over the last 10 years.
LowestHighest
Its median0.31%Industry median0.60%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +27.1% | −43.1% | +123.1% | 0.3% |
| 3 years | +11.5% | −14.0% | +29.3% | 0.3% |
| 5 years | +1.9% | +10.7% | −8.2% | 0.3% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 5 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count. Earnings growth over 1, 3 and 5 years includes one-off items (exceptional items and the result of businesses sold or closed) of more than a tenth of the profit of the years to Mar 2021 and Mar 2026.
Mutual fund holdings
68 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 44 of the 53 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future.All 68 funds holding Zydus Wellness
- AddedAdded. Funds that held more shares than at the end of the month before.
- 16
- CutCut. Funds that held fewer shares than at the end of the month before.
- 37
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 15
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end. Sold out in the glossary
- 1
| Fund | |||
|---|---|---|---|
 Parag Parikh Flexi Cap FundPPFAS Mutual Fund | 2,21,57,154 | 0.78% | ₹1,136.2 Cr |
 Nippon India Small Cap FundNippon India Mutual Fund | 1,71,32,587 | 1.09% | ₹878.6 Cr |
 quant Small Cap Fundquant Mutual Fund | 89,98,186 | 1.30% | ₹461.4 Cr |
| quant Multi Cap Fundquant Mutual Fund | 16,75,485 | 1.15% | ₹85.9 Cr |
 Bajaj Finserv Small Cap FundBajaj Finserv Mutual Fund | 15,04,582 | 2.79% | ₹77.2 Cr |
| Parag Parikh ELSS Tax Saver FundPPFAS Mutual Fund | 11,63,620 | 1.10% | ₹59.7 Cr |
| Nippon India Consumption FundNippon India Mutual Fund | 10,92,134 | 2.48% | ₹56.0 Cr |
| quant Manufacturing Fundquant Mutual Fund | 10,56,863 | 7.60% | ₹54.2 Cr |
| Bajaj Finserv Multi Cap FundBajaj Finserv Mutual Fund | 7,74,387 | 2.42% | ₹39.7 Cr |
| Bajaj Finserv Large & Mid Cap FundBajaj Finserv Mutual Fund | 6,54,569 | 1.44% | ₹33.6 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Promoter and insider buying and selling
Trades made since 29 Oct 2025.Zydus Wellness insider trading
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Promoters and promoter group3 purchases, 0 sales₹0.10 CrNo saleNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.₹0.10 Cr2 off-market moves
- Directors and key managers2 purchases, 0 sales₹0.05 CrNo saleNet₹0.05 Cr
- Employees9 purchases, 0 sales₹0.62 CrNo saleNet₹0.62 Cr
- Others1 purchase, 1 sale₹0.20 Cr₹0.01 CrNet₹0.19 Cr
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Zydus Wellness competitors and peers
Packaged Foods, 54 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Zydus Wellness in market cap.FMCG companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Nestle IndiaNESTLEIND | 2,25,227 | 55.24 | 38.99 | +21.7% | +38.2% | 79.9% | 92.5% | 1.20% |
 Britannia IndustriesBRITANNIA | 1,10,012 | 42.25 | 21.54 | +6.6% | +18.7% | 55.0% | 50.7% | 1.98% |
 Bikaji Foods InternationalBIKAJI | 11,556 | 44.70 | 7.19 | +13.8% | +27.9% | 17.3% | 16.4% | 0.27% |
 The Bombay Burmah Trading CorporationBBTC | 8,226 | 6.38 | 1.17 | +6.6% | +13.1% | 20.4% | 28.6% | 1.44% |
 Mrs. Bectors Food SpecialitiesBECTORFOOD | 5,582 | 37.52 | 4.39 | +11.1% | +7.3% | 12.2% | 12.6% | 0.72% |
 Gopal SnacksGOPAL | 3,056 | 36.39 | 6.38 | +12.0% | – | 19.0% | 12.1% | 0.41% |
 ADF FoodsADFFOODS | 2,650 | 28.81 | 4.63 | +19.4% | +31.2% | 17.3% | 19.6% | 0.50% |
 Prataap SnacksDIAMONDYD | 2,518 | 219.06 | 3.60 | +6.4% | – | 1.7% | 2.3% | 0.05% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Zydus Wellness dividend history
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up. Dividend per share in the glossaryHighest ₹1.60 a share, year to Mar 2018.
| Ex-date | Type | Per share |
|---|---|---|
| 17 Jul 2026 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. Final dividend in the glossary | ₹1.20 |
| 11 Jul 2025 | Final | ₹6.00 |
| 19 Jul 2024 | Final | ₹5.00 |
| 21 Jul 2023 | Final | ₹5.00 |
| 14 Jul 2022 | Final | ₹5.00 |
| 14 Jul 2021 | Final | ₹5.00 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Zydus Wellness announcements
Oct 2026
23 Oct · News Verification
The exchange asked on 22 Oct 2026
19 Oct · Analysts
16 Oct · General Updates
15 Oct · Board meeting
Sep 2026
18 Sep · Management
18 Sep · Management
Zydus Wellness share price by year
Each calendar year to 2025.Zydus Wellness share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 454.60 | +15.3% | 524.26 | 307.08 |
| 2024 | 394.25 | +17.3% | 479.56 | 294.77 |
| 2023 | 336.22 | +11.6% | 336.22 | 279.41 |
| 2022 | 301.36 | −20.0% | 378.32 | 292.89 |
| 2021 | 376.90 | −5.3% | 483.60 | 371.18 |
| 2020 | 398.10 | +35.4% | 398.10 | 237.65 |
| 2019 | 294.06 | +8.1% | 364.27 | 247.39 |
| 2018 | 272.09 | +30.4% | 352.30 | 194.38 |
| 2017 | 208.64 | +20.4% | 208.64 | 162.73 |
| 2016 | 173.23 | +0.3% | 181.09 | 129.11 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 27 Oct 2026 | 469.80 | 482.30 | 465.25 | 472.00 | 473.08 | 90,804 | 40.4% |
| 26 Oct 2026 | 461.65 | 476.90 | 455.00 | 474.10 | 468.64 | 68,110 | 42.8% |
| 23 Oct 2026 | 474.25 | 475.00 | 454.45 | 463.35 | 462.44 | 1,44,936 | 46.0% |
| 22 Oct 2026 | 486.05 | 492.00 | 472.05 | 475.30 | 480.60 | 1,18,689 | 47.1% |
| 21 Oct 2026 | 515.95 | 516.45 | 487.00 | 492.00 | 498.96 | 87,159 | 42.7% |
| 19 Oct 2026 | 511.55 | 516.75 | 501.55 | 515.40 | 509.70 | 61,362 | 44.3% |
| 16 Oct 2026 | 512.85 | 515.00 | 506.30 | 512.75 | 511.45 | 52,401 | 43.3% |
| 15 Oct 2026 | 514.95 | 515.30 | 505.05 | 509.95 | 510.02 | 96,977 | 50.3% |
| 14 Oct 2026 | 500.00 | 520.00 | 496.65 | 517.10 | 512.72 | 1,98,330 | 45.2% |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Stock split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 18 Sep 2025 | Split | 0.2000 | Each share became 5. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- NSE symbol
- ZYDUSWELL
- BSE code
- 531335
- ISIN
- INE768C01028
- Industry
- Food Products
- Website
- www.zyduswellness.com
- CIN
- L15201GJ1994PLC023490
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 1994
- Registered office
- Scheme No. 63,, Zydus Corporate Park,, Survey No. 536,, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle, Sarkhej, Ahmedabad 382481, Gujarat
- Share registrar
- MUFG Intime India Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments
In Nifty 500, BSE 500, Nifty Smallcap 250, BSE 250 SmallCap Index, BSE SmallCap, Nifty Total Market